Nachrichten zur Viatris Inc. Aktie

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Viatris Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – VTRS

NEW YORK, April 22, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law…

Viatris Inc. Class Action: Levi & Korsinsky Reminds Viatris Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of June 3, 2025 – VTRS

NEW YORK, April 21, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Viatris Inc. ("Viatris"…

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Viatris Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – VTRS

NEW YORK, April 19, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law…

VTRS INVESTOR NEWS: Viatris Inc. Investors may be able to Recover Losses in Class Action Lawsuit -- Contact BFA Law before June 3 Deadline (NASDAQ:VTRS)

Viatris Inc. investors that lost money are encouraged to contact BFA Law before June 3, 2025 class action deadline.…

ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Viatris Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – VTRS

NEW YORK, April 13, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm,…

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Viatris Inc. of Class Action Lawsuit and Upcoming Deadlines - VTRS

NEW YORK, April 12, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been…

3 Beaten-Down Stocks That Are Trading Below Their Book Values

A companys book value is equal to its total assets, less its liabilities. Book value does not consider the future…

Rosen Law Firm Encourages Viatris Inc. Investors to Inquire About Securities Class Action Investigation

Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of…

Viatris Inc. (VTRS) Barclays 27th Annual Global Healthcare Conference (Transcript)

…

Whats in the Cards for Viatris Stock This Q4 Earnings?

VTRS Q4 results are likely to gain from new product launches in all major geographies.…

Viatris Inc. (VTRS) 43rd Annual J.P. Morgan Healthcare Conference 2025 (Transcript)

…

FDA restricts import of certain Viatris products due to plant violations By Investing.com

FDA restricts import of certain Viatris products due to plant violations…

Viatris Inc. (VTRS) Management Presents at Jefferies London Healthcare Conference (Transcript)

…

Viatris Inc. (VTRS) UBS Global Healthcare Conference (Transcript)

…

Theravances Q3 Loss Narrower Than Expected, Revenues Rise Y/Y

TBPH beats third-quarter estimates for both sales and earnings. Increased collaboration revenues from Viatris drive year-over-year top-line performance.…

Viatris Inc. (VTRS): A Strategic Shift in Healthcare Investments

We recently published a list of 8 Stocks Under $20 To Invest In Now. In this article, we are going…

Aktienmarkt: Kurs der Viatris-Aktie im Minus (10,0972 €)

An der US-amerikanischen Börse notiert das Wertpapier von Viatris zur Stunde leichter. Der jüngste Kurs betrug 11,20 US-Dollar. An der…

US Biosimilar Market Research 2024-2028 Featuring Leading Players - Pfizer, Novartis, Amgen, Samsung Biologics, Celltrion, and Viatris

Dublin, Aug. 12, 2024 (GLOBE NEWSWIRE) -- The "US Biosimilar Market: Insights & Forecast (2024-2028)" report has been…

Viatris Inc. (VTRS) Q2 2024 Earnings Call Transcript

…

Theravance (TBPH) Q2 Loss Wider Than Expected, Revenues Rise Y/Y

Theravance (TBPH) misses second-quarter estimates on both fronts. Increased collaboration revenues from Viatris drive year-over-year top-line performance.…

Viatris Inc. (VTRS) Goldman Sachs 45th Annual Global Healthcare Conference (Transcript)

…

Viatris Inc. (VTRS) Presents at Jefferies 2024 Global Healthcare Conference (Transcript)

…

Global Topical Wound Agents Market Size To Exceed USD 3.7 Billion By 2033 | CAGR Of 6.89%

The Global Topical Wound Agents Market Size was valued at USD 1.9 Billion in 2023 and the Global Topical Wound…

Viatris Inc. (VTRS) BofA Securities 2024 Health Care Conference (Transcript)

…

Analyst Report: Viatris Inc

…

Viatris Inc. (VTRS) Q1 2024 Earnings Call Transcript

…

Inflation Reduction Act: A Bullish Catalyst For Viatris Inc.

…

Viatris Stock: Way Too Undervalued With $1 Billion Buyback Potential

…

Teva, Viatris win new chance to challenge J&J schizophrenia drug patent By Reuters

Teva, Viatris win new chance to challenge J&J schizophrenia drug patent…

Ocuphire Announces the U.S. Commercial Launch of RYZUMVl™ (Phentolamine Ophthalmic Solution 0.75%) by its Partner Viatris

FARMINGTON HILLS, Mich., April 01, 2024 (GLOBE NEWSWIRE) -- Ocuphire Pharma, Inc. (Nasdaq: OCUP), a clinical-stage biopharmaceutical company…

Nachrichten zur Viatris Inc. Aktie

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Viatris Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – VTRS

Viatris Inc. Class Action: Levi & Korsinsky Reminds Viatris Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of June 3, 2025 – VTRS

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Viatris Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – VTRS

VTRS INVESTOR NEWS: Viatris Inc. Investors may be able to Recover Losses in Class Action Lawsuit -- Contact BFA Law before June 3 Deadline (NASDAQ:VTRS)

ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Viatris Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – VTRS

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Viatris Inc. of Class Action Lawsuit and Upcoming Deadlines - VTRS

3 Beaten-Down Stocks That Are Trading Below Their Book Values

Rosen Law Firm Encourages Viatris Inc. Investors to Inquire About Securities Class Action Investigation

Viatris Inc. (VTRS) Barclays 27th Annual Global Healthcare Conference (Transcript)

Whats in the Cards for Viatris Stock This Q4 Earnings?

Viatris Inc. (VTRS) 43rd Annual J.P. Morgan Healthcare Conference 2025 (Transcript)

FDA restricts import of certain Viatris products due to plant violations By Investing.com

Viatris Inc. (VTRS) Management Presents at Jefferies London Healthcare Conference (Transcript)

Viatris Inc. (VTRS) UBS Global Healthcare Conference (Transcript)

Theravances Q3 Loss Narrower Than Expected, Revenues Rise Y/Y

Viatris Inc. (VTRS): A Strategic Shift in Healthcare Investments

Aktienmarkt: Kurs der Viatris-Aktie im Minus (10,0972 €)

US Biosimilar Market Research 2024-2028 Featuring Leading Players - Pfizer, Novartis, Amgen, Samsung Biologics, Celltrion, and Viatris

Viatris Inc. (VTRS) Q2 2024 Earnings Call Transcript

Theravance (TBPH) Q2 Loss Wider Than Expected, Revenues Rise Y/Y

Viatris Inc. (VTRS) Goldman Sachs 45th Annual Global Healthcare Conference (Transcript)

Viatris Inc. (VTRS) Presents at Jefferies 2024 Global Healthcare Conference (Transcript)

Global Topical Wound Agents Market Size To Exceed USD 3.7 Billion By 2033 | CAGR Of 6.89%

Viatris Inc. (VTRS) BofA Securities 2024 Health Care Conference (Transcript)

Analyst Report: Viatris Inc

Viatris Inc. (VTRS) Q1 2024 Earnings Call Transcript

Inflation Reduction Act: A Bullish Catalyst For Viatris Inc.

Viatris Stock: Way Too Undervalued With $1 Billion Buyback Potential

Teva, Viatris win new chance to challenge J&J schizophrenia drug patent By Reuters

Ocuphire Announces the U.S. Commercial Launch of RYZUMVl™ (Phentolamine Ophthalmic Solution 0.75%) by its Partner Viatris

Viatris Stock Is Still Worth Buying

Global Pregabalin Market Size To Worth USD 2.18 Billion By 2033 | CAGR of 2.82%

Viatris Inc. (VTRS) R&D Event (Transcript)

Viatris Inc. (VTRS) Q4 2023 Earnings Call Transcript

Viatris reports upbeat 2024 revenue outlook By Investing.com

dpa-AFX ProFeed